Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eric Sullivan Insider Profile
4 Followers
Eric Sullivan, CAO at Bluebird Bio, holds 3.22K shares in Bluebird Bio (Ticker: BLUE), holds ― shares in TCR2 Therapeutics (Ticker: TCRR). Most recently, Eric Sullivan Sold ― shares of Bluebird Bio on Aug 07, 2017 for an estimated value of 80.79K.
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-51.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
CAO
Roles that Eric Sullivan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Eric Sullivan
Eric Sullivan's Trading History
Bluebird Bio
Aug 07, 2017
CAO
Informative Sell
80.79K
$3.44K
TCR2 Therapeutics
―
―
―
―
List of latest transactions for each holding click on a transaction to see Eric Sullivan's performance on stock
You May Also Like
Eric Sullivan insider profile FAQ
What is the percentage of profitable transactions made by Eric Sullivan?
The percentage of profitable transactions made by Eric Sullivan is 20%.
What is the average return per transaction made by Eric Sullivan?
The average return per transaction made by Eric Sullivan is -51.60%.
What stocks does Eric Sullivan hold?
Eric Sullivan holds: BLUE, TCRR stocks.
What was Eric Sullivan’s latest transaction?
Eric Sullivan latest transaction was an Informative Sell of $80.79K.
What was Eric Sullivan's most profitable transaction?
Eric Sullivan’s most profitable transaction was an Informative Sell of BLUE stock on July 21, 2015. The return on the trade was 69.50%.
What is Eric Sullivan's role in Bluebird Bio?
Eric Sullivan's role in Bluebird Bio is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.